Literature DB >> 20812053

[Microvascular and macrovascular complications in children and adolescents with type 1 diabetes mellitus].

Elke E Fröhlich-Reiterer1, Martin H Borkenstein.   

Abstract

Diabetes-related microvascular and macrovascular complications, as retinopathy, nephropathy and neuropathy are life-threatening complications in children and adolescents with type 1 diabetes mellitus (T1DM). Risk factors for the development of complications are longer duration of diabetes, older age and puberty. Further risk factors include smoking, hypertension, higher body mass index and dyslipoproteinaemia. Therefore prevention and screening for complications is an important part in the care of children and adolescents with T1DM. Target levels to reduce the risk of microvascular and macrovascular complications in children and adolescents with T1DM are the following: HbA1c<7.5%, lipids in normal range, blood pressure<90th percentile by age, sex and height, BMI<95th percentile, no smoking and physical activity. Screening for retinopathy and microalbuminuria should start from 11 years with two years diabetes duration and from 9 years with 5 years duration and after 2 years diabetes duration in an adolescent. Thereafter screening should be performed annually. Blood pressure should be measured at least annually. Screening for fasting blood lipids should be performed soon after diagnosis in all children with T1DM aged over 12 years. If normal results are obtained, this should be repeated every 5 years.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812053     DOI: 10.1007/s10354-010-0816-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  18 in total

1.  The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis.

Authors:  Raelene E Maser; Braxton D Mitchell; Aaron I Vinik; Roy Freeman
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

2.  The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes.

Authors:  C C Bailey; J M Sparrow; R H Grey; H Cheng
Journal:  Eye (Lond)       Date:  1999-04       Impact factor: 3.775

Review 3.  Prevention of diabetic renal disease with special reference to microalbuminuria.

Authors:  C E Mogensen; W F Keane; P H Bennett; G Jerums; H H Parving; P Passa; M W Steffes; G E Striker; G C Viberti
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

4.  Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.

Authors:  Maria Nordwall; Hans J Arnqvist; Mats Bojestig; Johnny Ludvigsson
Journal:  Pediatr Diabetes       Date:  2008-10-22       Impact factor: 4.866

5.  A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension.

Authors:  Beth Soffer; Zhongxin Zhang; Kenneth Miller; Beth A Vogt; Shahnaz Shahinfar
Journal:  Am J Hypertens       Date:  2003-10       Impact factor: 2.689

6.  Family histories of Type II diabetes and hypertension predict intima-media thickness in patients with Type I diabetes.

Authors:  S Mäkimattila; K Ylitalo; A Schlenzka; M-R Taskinen; P Summanen; M Syvänne; H Yki-Järvinen
Journal:  Diabetologia       Date:  2002-04-17       Impact factor: 10.122

7.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

8.  Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.

Authors:  S P Laing; A J Swerdlow; S D Slater; A C Burden; A Morris; N R Waugh; W Gatling; P J Bingley; C C Patterson
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

9.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.

Authors:  M J Young; A J Boulton; A F MacLeod; D R Williams; P H Sonksen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

10.  Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin.

Authors:  Saskia de Jongh; Leiv Ose; Tamás Szamosi; Claude Gagné; M Lambert; Russell Scott; P Perron; Dries Dobbelaere; M Saborio; Mary B Tuohy; Michael Stepanavage; Aditi Sapre; Barry Gumbiner; Michele Mercuri; A S Paul van Trotsenburg; Henk D Bakker; John J P Kastelein
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

View more
  3 in total

1.  Actin cytoskeletal rearrangement and dysfunction due to activation of the receptor for advanced glycation end products is inhibited by thymosin beta 4.

Authors:  Sokho Kim; Jungkee Kwon
Journal:  J Physiol       Date:  2015-02-27       Impact factor: 5.182

2.  Association of homocysteine with type 1 diabetes mellitus: a meta-analysis.

Authors:  Yu Feng; Mei-Qin Shan; Lin Bo; Xiao-Yan Zhang; Ji Hu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Effects of Motivational Interviewing on Adherence to Treatment Regimens Among Patients With Type 1 Diabetes: A Systematic Review.

Authors:  Nahid Dehghan-Nayeri; Fatemeh Ghaffari; Tahereh Sadeghi; Naser Mozaffari
Journal:  Diabetes Spectr       Date:  2019-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.